Beyond the Invisible: Understanding the Impact of hEDS and HSD on Sexual Health

For many patients navigating the complexities of hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD), the clinical encounter is often a triage of urgent symptoms: joint dislocations, chronic fatigue, dysautonomia, and widespread pain. In this landscape, sexual health is frequently relegated to the periphery—viewed as a private concern rather than a clinical one. However, a landmark study from the Mayo Clinic’s EDS Clinic in Florida is shifting this narrative, providing compelling evidence that sexual dysfunction is not merely a byproduct of chronic illness, but a distinct challenge for those living with hypermobility.

Main Facts: A New Clinical Perspective

A recent study published in Frontiers in Reproductive Health represents one of the most comprehensive investigations into the sexual health of individuals with hEDS and HSD. By analyzing data from 1,407 patients, researchers have successfully bridged the gap between anecdotal patient experiences and empirical clinical data.

The study aimed to answer a fundamental question: Is sexual dysfunction in these populations an inevitable consequence of living with chronic pain, or is there a specific, hypermobility-related etiology? By utilizing a control group composed of individuals with chronic pain who do not have a hypermobility diagnosis, the research team was able to isolate variables specific to collagen and connective tissue dysfunction, effectively stripping away the "noise" created by generalized chronic pain.

The findings are stark. Women with hEDS reported significantly higher rates of sexual impairment across multiple domains—including desire, arousal, and physical pain—compared to their chronic pain counterparts. This suggests that the physiological instability inherent in hEDS directly correlates with the disruption of sexual well-being.

Chronology: The Evolution of the Research

The timeline of this study spans from 2020 to 2025, a period during which awareness of EDS and HSD has grown globally.

  • 2020–2024 (Data Collection): Researchers at the Mayo Clinic Florida EDS Clinic implemented a standardized, validated screening questionnaire for all incoming patients. This ensured a consistent longitudinal dataset, capturing a wide spectrum of sexual health indicators, ranging from psychological factors like sexual anxiety to physiological markers like vaginal dryness and pelvic floor stability.
  • Late 2025 (Synthesis): The team processed the data of 1,407 participants, categorizing them into three distinct cohorts: those with hEDS, those with HSD, and the chronic pain control group.
  • November 2026 (Publication): The findings were released, providing the medical community with a robust framework to understand how connective tissue disorders intersect with sexual anatomy and psychology.

Supporting Data: Dissecting the Numbers

The statistical breakdown reveals a significant disparity, particularly for female patients. Among the 1,407 participants, 69% were diagnosed with HSD, 17% with hEDS, and 14% served as the chronic pain control group. Given the known sex-based prevalence of these conditions, the cohort was approximately 90% female.

The hEDS Experience

The data for women with hEDS was the most striking. Nearly 70% of women in this group reported sexual problems, compared to 57% in the control group. When disaggregated into specific categories, the gap widens:

  • Sexual Interest: 41% (hEDS) vs. 30% (controls)
  • Sexual Pain (Dyspareunia): 45% (hEDS) vs. 31% (controls)
  • Difficulty with Orgasm: 34% (hEDS) vs. 23% (controls)

The Gender Divergence

Perhaps the most intriguing data point involves male patients. Unlike the female cohort, males with hEDS did not report significantly higher rates of sexual dysfunction compared to the control group. This divergence provides a critical clue: the heightened burden in females may be tied to the unique biomechanics of the female pelvic floor, which is heavily reliant on collagen integrity for structural support during sexual activity.

The HSD Distinction

Patients with HSD presented a different profile. While both men and women with HSD reported higher instances of low sexual interest, the study found fewer significant differences in other categories compared to the hEDS group. This suggests that while HSD impacts quality of life, the specific connective tissue laxity in hEDS may create a more complex landscape of physical barriers to sexual health.

Official Responses and Clinical Implications

The medical community has long lacked specific guidance on how to manage the sexual health of hypermobile patients. This study serves as a call to action for rheumatologists, geneticists, and primary care physicians to broaden the scope of their clinical assessments.

Sexual Problems in hEDS and HSD: More Common Than You Think

The "Systemic" Approach

The authors of the study argue that sexual problems in hEDS patients should be approached through a multi-disciplinary lens. Because the pelvic region is a complex nexus of nerves, muscles, and connective tissue, isolated treatments are rarely sufficient. The study advocates for:

  1. Pelvic Floor Physical Therapy: Targeted therapy to address hypertonicity or laxity in the pelvic floor muscles.
  2. Urological and Gynecological Integration: Addressing the high correlation between hEDS and recurrent urinary tract infections (37.1% in women), incontinence (30%), and yeast infections (22.9%).
  3. Endocrine Evaluation: Recognizing that hormonal fluctuations can exacerbate tissue fragility.

Challenging Assumptions

A critical implication of this research is the necessity of avoiding diagnostic overshadowing. For years, patients have been told that their pain is simply "part of having EDS." This study refutes that fatalism. By comparing hEDS patients to other chronic pain patients, researchers have proven that there is a measurable difference in the impact of hypermobility. Clinicians are now encouraged to treat these issues as symptomatic manifestations rather than unavoidable lifestyle consequences.

The Broader Context: Why This Matters

For the patient, this research validates a long-overlooked reality. For the clinician, it provides a roadmap for improved care. The implications of this study reach far beyond the exam room.

Addressing the "Invisible" Burden

Sexual dysfunction carries a heavy psychological weight. It impacts self-esteem, intimate relationships, and overall life satisfaction. By bringing this topic into the mainstream clinical dialogue, the Mayo Clinic study helps dismantle the stigma that prevents patients from speaking up. When a doctor proactively asks about sexual health during an intake appointment, it signals to the patient that their quality of life—not just their joint stability—is a priority.

A Note on Differential Diagnosis

While this study illuminates the relationship between hEDS and sexual dysfunction, it also serves as a reminder of the importance of differential diagnosis. The study authors, along with experts at Chronic Pain Partners, emphasize that not all pain should be attributed to hEDS. Conditions such as endometriosis, pelvic congestion syndrome, and mast cell activation syndrome (MCAS) are frequent comorbidities that require their own specific, targeted interventions. Attributing all sexual pain to "just EDS" could result in missing underlying conditions that are highly treatable.

Conclusion: A Path Forward

The path to improved sexual health for those with hEDS and HSD begins with open, honest, and scientifically informed communication. We are moving away from an era of silence and into an era of evidence-based advocacy.

Patients are encouraged to utilize this research as a tool. If your current care plan does not address your sexual health, bring these findings to your next appointment. Ask for a referral to a pelvic floor specialist, request a thorough urological screening, and demand that your quality of life be treated with the same rigor as your joint health.

As we continue to better understand the systemic impacts of hypermobility, it becomes increasingly clear that holistic care is the only path forward. Sexual health is, fundamentally, health. By acknowledging this, we empower those with hEDS and HSD to live more full, connected, and supported lives.


References & Further Reading

  • Frontiers in Reproductive Health: "Sexual Problems in hEDS and HSD: A Comprehensive Analysis" (2026).
  • Chronic Pain Partners Clinical Guidelines for Multi-disciplinary EDS Management.
  • International Society for the Study of Women’s Sexual Health (ISSWSH) standards on connective tissue-related pelvic dysfunction.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional regarding any medical conditions or symptoms.

More From Author

The First Seven Days: A Blueprint for Resilience in an Age of Global Instability

Redefining Relief: How Southwest Florida Pain Center is Pioneering Non-Pharmacological Interventional Care